Long-lasting angiotensin type 1 receptor binding and protection by candesartan: comparison with other biphenyl-tetrazole sartans

International union of pharmacology. XXIII. The angiotensin II receptors.

2000 • 2,055 citations

Angiotensin II receptors and angiotensin II receptor antagonists.

1993 • 1,843 citations

G Protein-Coupled Receptor Allosterism and Complexing

2002 • 910 citations

Preliminary biochemical characterization of two angiotensin II receptor subtypes

1989 • 779 citations

Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function

2003 • 439 citations

Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT₁‐receptor subtype

1993 • 254 citations

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

1991 • 249 citations

Side-Chain Substitutions within Angiotensin II Reveal Different Requirements for Signaling, Internalization, and Phosphorylation of Type 1A Angiotensin Receptors

2002 • 235 citations

Intracellular Trafficking of Angiotensin II and its AT₁and AT₂Receptors: Evidence for Selective Sorting of Receptor and Ligand

1997 • 227 citations

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277

1993 • 192 citations

Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.

1993 • 182 citations

A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients A placebo-controlled, forced titration study

1999 • 166 citations

Distinction between surmountable and insurmountable selective AT₁ receptor antagonists by use of CHO‐K1 cells expressing human angiotensin II AT₁ receptors

1999 • 144 citations

Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist

1993 • 143 citations

Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor

1997 • 139 citations

Mechanistic Differences of Various AT ₁ -Receptor Blockers in Isolated Vessels of Different Origin

1999 • 125 citations

Role of Aromaticity of Agonist Switches of Angiotensin II in the Activation of the AT1 Receptor

1999 • 101 citations

A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism

1997 • 94 citations

Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding

1999 • 88 citations

Binding of the antagonist []candesartan to angiotensin II AT1 receptor-tranfected Chinese hamster ovary cells

1999 • 86 citations

Pharmacological properties of angiotensin II receptor antagonists.

1999 • 80 citations

Newly emerging pharmacologic differences in angiotensin II receptor blockers

2000 • 79 citations

Pharmacological profile of GR117289 in vitro: a novel, potent and specific non‐peptide angiotensin AT₁ receptor antagonist

1992 • 76 citations

The Comparative Pharmacology of Angiotensin II Receptor Antagonists

2001 • 71 citations

Significance of angiotensin type 1 receptor blockade: why are angiotensin II receptor blockers different?

1999 • 69 citations

A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists

2001 • 60 citations

Functional studies but not receptor binding can distinguish surmountable from insurmountable AT1 antagonism.

1995 • 55 citations

Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors

2000 • 51 citations

Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors

2000 • 50 citations

Blockade of nicotinic receptor‐mediated release of dopamine from striatal synaptosomes by chlorisondamine administeredin vivo

1994 • 48 citations

Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception

1997 • 43 citations

Pharmacological Properties of KT3–671, a Novel Nonpeptide Angiotensin II Receptor Antagonist

1995 • 42 citations

Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists

2000 • 40 citations

BMS‐180560, an insurmountable inhibitor of angiotensin II‐stimulated responses: comparison with losartan and EXP3174

1994 • 36 citations

Distinct binding properties of the AT1 receptor antagonist [3H]candesartan to intact cells and membrane preparations

2002 • 35 citations

In vitro pharmacological characterization of a new selective angiotensin AT1 receptor antagonist, UR-7280

1996 • 34 citations

Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cells

2005 • 28 citations

Angiotensin type-2 receptors and cardiovascular function: are angiotensin type-2 receptors protective?

2005 • 27 citations

Kinetic studies on the interaction of nonlabeled antagonists with the angiotensin II receptor

1995 • 25 citations

Angiotensin II‐mediated calcium signals and mitogenesis in human prostate stromal cell line hPCPs

2004 • 24 citations

Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan

1999 • 21 citations

Binding characteristics of [3H]-irbesartan to human recombinant angiotensin type 1 receptors

2000 • 20 citations

Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT1 receptor antagonist

1995 • 20 citations

Different apparent modes of inhibition of α2A-adrenoceptor by α2-adrenoceptor antagonists

1997 • 19 citations

Effect of saponin and filipin on antagonist binding to AT1 receptors in intact cells

2004 • 17 citations

Pharmacology of XR510, a Potent Orally Active Nonpeptide Angiotensin II AT1 Receptor Antagonist with High Affinity for the AT2 Receptor Subtype

1995 • 16 citations

Pharmacology of LR-B/057, a Novel Orally Active AT1 Receptor Antagonist

1995 • 15 citations

Distinctions between non-peptide angiotensin II AT1-receptor antagonists

2001 • 15 citations

Role of basic amino acids of the human angiotensin type 1 receptor in the binding of the non-peptide antagonist candesartan

2001 • 15 citations

Antagonist interaction with endogenous AT1 receptors in human cell lines

2002 • 10 citations

In Vitro Pharmacological Properties of KRH-594, a Novel Angiotensin II Type 1 Receptor Antagonist.

1997 • 9 citations

AT1 Receptor Interactions

2004 • 1 citations